Clin2
NCT07743931Possibly a fitNot yet recruiting

Combined CPAP and medication for sleep apnea with insomnia

Obstructive Sleep Apnea (OSA)InsomniaCOMISA

Treatments studied

Part of Brain & nervous system, Lungs & breathing, Mental health clinical trials.

This study is testing a new approach for people who have both sleep apnea and insomnia, called 'COMISA'. It looks at whether using a CPAP machine together with a medication (daridorexant) helps improve their sleep better than standard care.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
150 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are an adult (18 years or older).
  • You have both sleep apnea (moderate to severe) and insomnia, as diagnosed by your doctor.
  • You have never used a CPAP machine or taken daridorexant for these conditions, or you haven't used them for more than 5 years.
  • Your doctor has prescribed both a CPAP machine and a medication called daridorexant as part of your treatment plan.
  • You are willing to participate and have signed a consent form.
  • You are not participating in this study just because you are a staff member under the principal investigator's supervision.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07556432Not yet recruiting
Early insomnia treatment to improve CPAP use in sleep apnea

This study tests whether treating insomnia early can help people newly diagnosed with sleep apnea stick with their CPAP machine. You'll receive a digital program on your smartphone to address sleep problems while starting CPAP therapy.

NCT07679282Not yet recruiting· Phase 4
Comparing sleep apnea treatments: CPAP, mouthpiece, or medication

This study compares three treatments for obstructive sleep apnea: a CPAP machine, a dental mouthpiece, and a combination of two medications (atomoxetine and oxybutynin). Researchers want to see which works best for people recently diagnosed with sleep apnea.

Tucson, Arizona
NCT07555743Not yet recruiting· Phase 4
New Insomnia Treatment for Depression Patients

This study tests whether a new sleep medication called daridorexant helps people with depression who also struggle with insomnia. You would take this medication for several weeks while researchers track how it affects your sleep and mood.

Barcelona, Catalonia
NCT07701928Not yet recruiting· Phase 2
Daridorexant for sleep and alcohol use disorder

This trial tests if the sleep medication daridorexant can help people who have both insomnia and alcohol use disorder. It looks at whether the drug improves sleep and reduces drinking.

Spokane, Washington
NCT04538755Enrolling by invitation· Phase 1/Phase 2
Testing a new drug for moderate to severe sleep apnea

This trial tests a drug called DAW2020 to see if it can improve how your body controls breathing during sleep. You may qualify if you have moderate to severe sleep apnea and are otherwise healthy.

Boston, Massachusetts
NCT07255027Not yet recruiting
Sleep therapy with anesthesia for stubborn insomnia

This trial tests if a sleep therapy using anesthesia can help people with long-term insomnia that hasn't improved with other treatments. It aims to improve sleep and daytime symptoms like mood or concentration problems.

Hear when a new Insomnia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.